A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
| Image |  |
|---|---|
| Description | scientific article published on 27 November 2019 |
| Author/s |
author: Ghazaleh Tabatabai Filip Y F L de Vos Martin J van den Bent Wolfgang Wick Patrick Y Wen |
| Publication date | November 27, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |